10x Genomics, Inc.
TXG
$14.01
-$0.27-1.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 172.91M | 154.88M | 165.02M | 151.65M | 153.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 172.91M | 154.88M | 165.02M | 151.65M | 153.10M |
| Cost of Revenue | 47.42M | 49.44M | 54.07M | 45.26M | 48.88M |
| Gross Profit | 125.48M | 105.45M | 110.96M | 106.39M | 104.22M |
| SG&A Expenses | 72.71M | 89.73M | 93.83M | 81.70M | 83.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 177.46M | 203.41M | 214.86M | 193.14M | 194.84M |
| Operating Income | -4.55M | -48.53M | -49.84M | -41.49M | -41.74M |
| Income Before Tax | 37.00M | -33.51M | -48.38M | -34.44M | -37.08M |
| Income Tax Expenses | 2.46M | 852.00K | 648.00K | 1.32M | 818.00K |
| Earnings from Continuing Operations | 34.54M | -34.36M | -49.03M | -35.75M | -37.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.54M | -34.36M | -49.03M | -35.75M | -37.90M |
| EBIT | -4.55M | -48.53M | -49.84M | -41.49M | -41.74M |
| EBITDA | 3.26M | -40.51M | -41.09M | -32.52M | -32.77M |
| EPS Basic | 0.28 | -0.28 | -0.40 | -0.30 | -0.32 |
| Normalized Basic EPS | 0.01 | -0.22 | -0.25 | -0.18 | -0.19 |
| EPS Diluted | 0.28 | -0.28 | -0.40 | -0.30 | -0.32 |
| Normalized Diluted EPS | 0.01 | -0.22 | -0.25 | -0.18 | -0.19 |
| Average Basic Shares Outstanding | 123.76M | 122.61M | 121.60M | 120.73M | 120.07M |
| Average Diluted Shares Outstanding | 124.51M | 122.61M | 121.60M | 120.73M | 120.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |